Last reviewed · How we verify
PalinGen Flow Amniotic Tissue Allograft — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
PalinGen Flow Amniotic Tissue Allograft (PalinGen Flow Amniotic Tissue Allograft) — Amnio Technology, LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PalinGen Flow Amniotic Tissue Allograft TARGET | PalinGen Flow Amniotic Tissue Allograft | Amnio Technology, LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PalinGen Flow Amniotic Tissue Allograft CI watch — RSS
- PalinGen Flow Amniotic Tissue Allograft CI watch — Atom
- PalinGen Flow Amniotic Tissue Allograft CI watch — JSON
- PalinGen Flow Amniotic Tissue Allograft alone — RSS
Cite this brief
Drug Landscape (2026). PalinGen Flow Amniotic Tissue Allograft — Competitive Intelligence Brief. https://druglandscape.com/ci/palingen-flow-amniotic-tissue-allograft. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab